 | • レポートコード：GIR-107A14775 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、治療用ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。治療用ペプチドの種類別市場規模（経口、注射、その他）、用途別市場規模（がん、代謝性疾患、中枢神経系、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・治療用ペプチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、AstraZeneca、Ipsen、Eli Lilly、Merck、Novo Nordisk、Novartis、Johnson and Johnson、Sanofi、Teva、Takeda ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射、その他 ・用途別分析2016年-2026年：がん、代謝性疾患、中枢神経系、その他 ・治療用ペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・治療用ペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・治療用ペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・治療用ペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・治療用ペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Therapeutic Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Therapeutic Peptide size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Therapeutic Peptide market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Therapeutic Peptide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Other
Market segment by Application can be divided into
Cancer
Metabolic Disorders
Central Nervous System
Other
The key market players for global Therapeutic Peptide market are listed below:
AbbVie
AstraZeneca
Ipsen
Eli Lilly
Merck
Novo Nordisk
Novartis
Johnson and Johnson
Sanofi
Teva
Takeda
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Therapeutic Peptide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Peptide, with price, sales, revenue and global market share of Therapeutic Peptide from 2019 to 2021.
Chapter 3, the Therapeutic Peptide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Peptide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Therapeutic Peptide market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Therapeutic Peptide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Therapeutic Peptide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Peptide Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Peptide Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Global Therapeutic Peptide Market Size & Forecast
1.4.1 Global Therapeutic Peptide Sales in Value (2016-2026))
1.4.2 Global Therapeutic Peptide Sales in Volume (2016-2026)
1.4.3 Global Therapeutic Peptide Price by Type (2016-2026) & (US$/Unit)
1.5 Global Therapeutic Peptide Production Capacity Analysis
1.5.1 Global Therapeutic Peptide Total Production Capacity (2016-2026)
1.5.2 Global Therapeutic Peptide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Therapeutic Peptide Market Drivers
1.6.2 Therapeutic Peptide Market Restraints
1.6.3 Therapeutic Peptide Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Therapeutic Peptide Product and Services
2.1.4 AbbVie Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Therapeutic Peptide Product and Services
2.2.4 AstraZeneca Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Ipsen
2.3.1 Ipsen Details
2.3.2 Ipsen Major Business
2.3.3 Ipsen Therapeutic Peptide Product and Services
2.3.4 Ipsen Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Therapeutic Peptide Product and Services
2.4.4 Eli Lilly Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Therapeutic Peptide Product and Services
2.5.4 Merck Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business
2.6.3 Novo Nordisk Therapeutic Peptide Product and Services
2.6.4 Novo Nordisk Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Therapeutic Peptide Product and Services
2.7.4 Novartis Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Johnson and Johnson
2.8.1 Johnson and Johnson Details
2.8.2 Johnson and Johnson Major Business
2.8.3 Johnson and Johnson Therapeutic Peptide Product and Services
2.8.4 Johnson and Johnson Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Therapeutic Peptide Product and Services
2.9.4 Sanofi Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Teva
2.10.1 Teva Details
2.10.2 Teva Major Business
2.10.3 Teva Therapeutic Peptide Product and Services
2.10.4 Teva Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Takeda
2.11.1 Takeda Details
2.11.2 Takeda Major Business
2.11.3 Takeda Therapeutic Peptide Product and Services
2.11.4 Takeda Therapeutic Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Therapeutic Peptide Sales by Manufacturer
3.1 Global Therapeutic Peptide Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Therapeutic Peptide Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Therapeutic Peptide
3.4 Market Concentration Rate
3.4.1 Top 3 Therapeutic Peptide Manufacturer Market Share
3.4.2 Top 6 Therapeutic Peptide Manufacturer Market Share
3.5 Global Therapeutic Peptide Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Therapeutic Peptide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Therapeutic Peptide Market Size by Region
4.1.1 Global Therapeutic Peptide Sales in Volume by Region (2016-2026)
4.1.2 Global Therapeutic Peptide Revenue by Region (2016-2026)
4.2 North America Therapeutic Peptide Revenue (2016-2026)
4.3 Europe Therapeutic Peptide Revenue (2016-2026)
4.4 Asia-Pacific Therapeutic Peptide Revenue (2016-2026)
4.5 South America Therapeutic Peptide Revenue (2016-2026)
4.6 Middle East and Africa Therapeutic Peptide Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Therapeutic Peptide Sales in Volume by Type (2016-2026)
5.2 Global Therapeutic Peptide Revenue by Type (2016-2026)
5.3 Global Therapeutic Peptide Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Therapeutic Peptide Sales in Volume by Application (2016-2026)
6.2 Global Therapeutic Peptide Revenue by Application (2016-2026)
6.3 Global Therapeutic Peptide Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Therapeutic Peptide Sales by Type (2016-2026)
7.2 North America Therapeutic Peptide Sales by Application (2016-2026)
7.3 North America Therapeutic Peptide Market Size by Country
7.3.1 North America Therapeutic Peptide Sales in Volume by Country (2016-2026)
7.3.2 North America Therapeutic Peptide Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Therapeutic Peptide Sales by Type (2016-2026)
8.2 Europe Therapeutic Peptide Sales by Application (2016-2026)
8.3 Europe Therapeutic Peptide Market Size by Country
8.3.1 Europe Therapeutic Peptide Sales in Volume by Country (2016-2026)
8.3.2 Europe Therapeutic Peptide Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Therapeutic Peptide Sales by Type (2016-2026)
9.2 Asia-Pacific Therapeutic Peptide Sales by Application (2016-2026)
9.3 Asia-Pacific Therapeutic Peptide Market Size by Region
9.3.1 Asia-Pacific Therapeutic Peptide Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Therapeutic Peptide Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Therapeutic Peptide Sales by Type (2016-2026)
10.2 South America Therapeutic Peptide Sales by Application (2016-2026)
10.3 South America Therapeutic Peptide Market Size by Country
10.3.1 South America Therapeutic Peptide Sales in Volume by Country (2016-2026)
10.3.2 South America Therapeutic Peptide Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Therapeutic Peptide Sales by Type (2016-2026)
11.2 Middle East & Africa Therapeutic Peptide Sales by Application (2016-2026)
11.3 Middle East & Africa Therapeutic Peptide Market Size by Country
11.3.1 Middle East & Africa Therapeutic Peptide Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Therapeutic Peptide Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Therapeutic Peptide Typical Distributors
12.3 Therapeutic Peptide Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Therapeutic Peptide Revenue by Type, (USD Million), 2021-2026
Table 2. Global Therapeutic Peptide Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Therapeutic Peptide Product and Services
Table 6. AbbVie Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Therapeutic Peptide Product and Services
Table 10. AstraZeneca Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Ipsen Basic Information, Manufacturing Base and Competitors
Table 12. Ipsen Major Business
Table 13. Ipsen Therapeutic Peptide Product and Services
Table 14. Ipsen Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 16. Eli Lilly Major Business
Table 17. Eli Lilly Therapeutic Peptide Product and Services
Table 18. Eli Lilly Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Therapeutic Peptide Product and Services
Table 22. Merck Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 24. Novo Nordisk Major Business
Table 25. Novo Nordisk Therapeutic Peptide Product and Services
Table 26. Novo Nordisk Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Therapeutic Peptide Product and Services
Table 30. Novartis Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson and Johnson Major Business
Table 33. Johnson and Johnson Therapeutic Peptide Product and Services
Table 34. Johnson and Johnson Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Therapeutic Peptide Product and Services
Table 38. Sanofi Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Teva Basic Information, Manufacturing Base and Competitors
Table 40. Teva Major Business
Table 41. Teva Therapeutic Peptide Product and Services
Table 42. Teva Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Takeda Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Major Business
Table 45. Takeda Therapeutic Peptide Product and Services
Table 46. Takeda Therapeutic Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Therapeutic Peptide Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Therapeutic Peptide Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Therapeutic Peptide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Therapeutic Peptide Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Therapeutic Peptide Production Site of Key Manufacturer
Table 52. Therapeutic Peptide New Entrant and Capacity Expansion Plans
Table 53. Therapeutic Peptide Mergers & Acquisitions in the Past Five Years
Table 54. Global Therapeutic Peptide Sales by Region (2016-2021e) & (K Units)
Table 55. Global Therapeutic Peptide Sales by Region (2021-2026) & (K Units)
Table 56. Global Therapeutic Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Therapeutic Peptide Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Therapeutic Peptide Sales by Type (2016-2021e) & (K Units)
Table 59. Global Therapeutic Peptide Sales by Type (2021-2026) & (K Units)
Table 60. Global Therapeutic Peptide Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Therapeutic Peptide Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Therapeutic Peptide Price by Type (2016-2021e) & (US$/Unit)
Table 63. Global Therapeutic Peptide Price by Type (2021-2026) & (US$/Unit)
Table 64. Global Therapeutic Peptide Sales by Application (2016-2021e) & (K Units)
Table 65. Global Therapeutic Peptide Sales by Application (2021-2026) & (K Units)
Table 66. Global Therapeutic Peptide Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Therapeutic Peptide Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Therapeutic Peptide Price by Application (2016-2021e) & (US$/Unit)
Table 69. Global Therapeutic Peptide Price by Application (2021-2026) & (US$/Unit)
Table 70. North America Therapeutic Peptide Sales by Country (2016-2021e) & (K Units)
Table 71. North America Therapeutic Peptide Sales by Country (2021-2026) & (K Units)
Table 72. North America Therapeutic Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Therapeutic Peptide Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Therapeutic Peptide Sales by Type (2016-2021e) & (K Units)
Table 75. North America Therapeutic Peptide Sales by Type (2021-2026) & (K Units)
Table 76. North America Therapeutic Peptide Sales by Application (2016-2021e) & (K Units)
Table 77. North America Therapeutic Peptide Sales by Application (2021-2026) & (K Units)
Table 78. Europe Therapeutic Peptide Sales by Country (2016-2021e) & (K Units)
Table 79. Europe Therapeutic Peptide Sales by Country (2021-2026) & (K Units)
Table 80. Europe Therapeutic Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Therapeutic Peptide Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Therapeutic Peptide Sales by Type (2016-2021e) & (K Units)
Table 83. Europe Therapeutic Peptide Sales by Type (2021-2026) & (K Units)
Table 84. Europe Therapeutic Peptide Sales by Application (2016-2021e) & (K Units)
Table 85. Europe Therapeutic Peptide Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific Therapeutic Peptide Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific Therapeutic Peptide Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific Therapeutic Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Therapeutic Peptide Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Therapeutic Peptide Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific Therapeutic Peptide Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific Therapeutic Peptide Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific Therapeutic Peptide Sales by Application (2021-2026) & (K Units)
Table 94. South America Therapeutic Peptide Sales by Country (2016-2021e) & (K Units)
Table 95. South America Therapeutic Peptide Sales by Country (2021-2026) & (K Units)
Table 96. South America Therapeutic Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Therapeutic Peptide Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Therapeutic Peptide Sales by Type (2016-2021e) & (K Units)
Table 99. South America Therapeutic Peptide Sales by Type (2021-2026) & (K Units)
Table 100. South America Therapeutic Peptide Sales by Application (2016-2021e) & (K Units)
Table 101. South America Therapeutic Peptide Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa Therapeutic Peptide Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa Therapeutic Peptide Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa Therapeutic Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Therapeutic Peptide Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Therapeutic Peptide Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa Therapeutic Peptide Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa Therapeutic Peptide Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa Therapeutic Peptide Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Therapeutic Peptide Typical Distributors
Table 113. Therapeutic Peptide Typical Customers
List of Figures
Figure 1. Therapeutic Peptide Picture
Figure 2. Global Therapeutic Peptide Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. Other
Figure 6. Global Therapeutic Peptide Sales Market Share by Application in 2020
Figure 7. Cancer
Figure 8. Metabolic Disorders
Figure 9. Central Nervous System
Figure 10. Other
Figure 11. Global Therapeutic Peptide Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Therapeutic Peptide Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Therapeutic Peptide Sales (2016-2026) & (K Units)
Figure 14. Global Therapeutic Peptide Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Therapeutic Peptide Production Capacity (2016-2026) & (K Units)
Figure 16. Global Therapeutic Peptide Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Therapeutic Peptide Market Drivers
Figure 18. Therapeutic Peptide Market Restraints
Figure 19. Therapeutic Peptide Market Trends
Figure 20. Global Therapeutic Peptide Sales Market Share by Manufacturer in 2020
Figure 21. Global Therapeutic Peptide Revenue Market Share by Manufacturer in 2020
Figure 22. Therapeutic Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Therapeutic Peptide Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Therapeutic Peptide Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Therapeutic Peptide Sales Market Share by Region (2016-2026)
Figure 26. Global Therapeutic Peptide Revenue Market Share by Region (2016-2026)
Figure 27. North America Therapeutic Peptide Revenue (2016-2026) & (USD Million)
Figure 28. Europe Therapeutic Peptide Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Therapeutic Peptide Revenue (2016-2026) & (USD Million)
Figure 30. South America Therapeutic Peptide Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Therapeutic Peptide Revenue (2016-2026) & (USD Million)
Figure 32. Global Therapeutic Peptide Sales Market Share by Type (2016-2026)
Figure 33. Global Therapeutic Peptide Revenue Market Share by Type (2016-2026)
Figure 34. Global Therapeutic Peptide Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Therapeutic Peptide Sales Market Share by Application (2016-2026)
Figure 36. Global Therapeutic Peptide Revenue Market Share by Application (2016-2026)
Figure 37. Global Therapeutic Peptide Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Therapeutic Peptide Sales Market Share by Type (2016-2026)
Figure 39. North America Therapeutic Peptide Sales Market Share by Application (2016-2026)
Figure 40. North America Therapeutic Peptide Sales Market Share by Country (2016-2026)
Figure 41. North America Therapeutic Peptide Revenue Market Share by Country (2016-2026)
Figure 42. United States Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Therapeutic Peptide Sales Market Share by Type (2016-2026)
Figure 46. Europe Therapeutic Peptide Sales Market Share by Application (2016-2026)
Figure 47. Europe Therapeutic Peptide Sales Market Share by Country (2016-2026)
Figure 48. Europe Therapeutic Peptide Revenue Market Share by Country (2016-2026)
Figure 49. Germany Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Therapeutic Peptide Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Therapeutic Peptide Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Therapeutic Peptide Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Therapeutic Peptide Revenue Market Share by Region (2016-2026)
Figure 58. China Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Therapeutic Peptide Sales Market Share by Type (2016-2026)
Figure 65. South America Therapeutic Peptide Sales Market Share by Application (2016-2026)
Figure 66. South America Therapeutic Peptide Sales Market Share by Country (2016-2026)
Figure 67. South America Therapeutic Peptide Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Therapeutic Peptide Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Therapeutic Peptide Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Therapeutic Peptide Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Therapeutic Peptide Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Therapeutic Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の寄生虫症治療市場 2021：企業別、地域別、種類・用途別 The Parasitic Diseases Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界の気管支拡張症治療市場 2021：企業別、地域別、種類・用途別 The Bronchiectasis Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のグルカゴン様ペプチド-2（GLP-2）アゴニスト市場 2021：企業別、地域別、種類・用途別 The Glucagon-like Peptide-2 (GLP-2) Agonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の糖尿病性足潰瘍治療市場 2021：企業別、地域別、種類・用途別 The Diabetic Foot Ulcer Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 血液疾患用診断及び治療市場：世界及び中国市場分析・予測（～2024年） Hematological Disorders Diagnostic And Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hematological Disorders Diagnostic And Therapeutic industry with a focus on the Chinese market. The report provides key statist…